Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05427214 · ClinicalTrials.gov registry record · NA
Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy
A NA study of Lung Cancer and Ovarian Cancer, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT05427214 is a NA study of Lung Cancer and Ovarian Cancer that has completed, run by Washington University School of Medicine. The registered enrollment target is 52 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05427214, a NA study of Lung Cancer and Ovarian Cancer, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective imaging study is evaluating the feasibility of using the Halcyon 4.0 radiotherapy system for radiation therapy planning in patients with cancer. The Halcyon 4.0 system has been engineered to decrease the image acquisition time and the radiation exposure, but the system has not yet been clinically validated for use in radiation planning. This pilot study will evaluate images obtained on the Halcyon 4.0 system to assess if the quality is sufficient for radiation treatment plan construction.
Conditions Studied
Interventions
- DEVICE Halcyon 4.0 system
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2022-08-19 |
| Est. Completion | 2024-10-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05427214
The ClinicalTrials.gov registry entry for NCT05427214 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Halcyon 4.0 system is the first listed.
NCT05427214 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT05427214 about?
NCT05427214 is a clinical study titled "Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy". This prospective imaging study is evaluating the feasibility of using the Halcyon 4.0 radiotherapy system for radiation therapy planning in patients with cancer. The Halcyon 4.0 system has been engineered to decrease the image acquisition time and the radiation exposure, but the system has not yet b...
What is the current status of trial NCT05427214?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2022-08-19. Estimated completion is 2024-10-17.
What conditions does trial NCT05427214 study?
This clinical trial studies the following conditions: Lung Cancer, Ovarian Cancer, Head and Neck Cancer, Gastric Cancer, Colon Cancer.
What interventions are being tested in trial NCT05427214?
The interventions under investigation include: Halcyon 4.0 system (DEVICE).
Who is sponsoring clinical trial NCT05427214?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05427214 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.